{"id":1812,"date":"2004-06-01T12:06:00","date_gmt":"2004-06-01T10:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/das-bfarm-gibt-bekannt"},"modified":"2022-03-17T14:10:40","modified_gmt":"2022-03-17T13:10:40","slug":"das-bfarm-gibt-bekannt","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2004\/das-bfarm-gibt-bekannt","title":{"rendered":"Das BfArM gibt bekannt:"},"content":{"rendered":"<p>Die Arzneimittelschnellinformationen (ASI, 2,04) berichten \u00fcber aktuelle Beobachtungen unerw\u00fcnschter Arzneimittelwirkungen (UAW), die beim Gebrauch von Arzneimitteln im genannten Zeitraum nach der Zulassung gemacht worden sind. Diese Meldungen \u00fcber UAW werden in zeitlichen Abst\u00e4nden regelm\u00e4\u00dfig in die Fachinformationen eingearbeitet. Die \u00c4nderungen der Fachinformationen spiegeln daher wider, welche UAW in der vorangegangenen Zeit in beachtenswerter Weise gemeldet [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die Arzneimittelschnellinformationen (ASI, 2,04) berichten \u00fcber aktuelle Beobachtungen unerw\u00fcnschter Arzneimittelwirkungen (UAW), die beim Gebrauch von Arzneimitteln im genannten Zeitraum nach der Zulassung gemacht worden sind. Diese Meldungen \u00fcber UAW werden in zeitlichen Abst\u00e4nden regelm\u00e4\u00dfig in die Fachinformationen eingearbeitet. Die \u00c4nderungen der Fachinformationen spiegeln daher wider, welche UAW in der vorangegangenen Zeit in beachtenswerter Weise gemeldet [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3993,74,255,77,76,302,594,3992,174,175,257,3994,303,172,298,297],"class_list":["post-1812","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-rs-23-bissulfanylpropan-1-sulfonsaeure","tag-acetylsalicylsaeure","tag-arzneimittel","tag-ass","tag-azetylsalizylsaeure","tag-beipackzettel","tag-ciclosporin","tag-dmps","tag-l-thyroxin","tag-levothyroxin","tag-medikamente","tag-naftidrofurylhydrogenoxalat","tag-packungsbeilage","tag-thyroxin","tag-waschzettel","tag-zulassungsstatus-von-arzneimitteln"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1812"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1812\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}